Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
ProShares S&P 500 Ex-Health Care ETF (SPXV) and Goldman Sachs MarketBeta U.S. Equity ETF (GSUS) belong to the same industry segment: US Large Cap. SPXV's top 3 sector exposures are Information Technology, Consumer Discretionary and Communication Services. In contrast, GSUS's top sector exposures are Information Technology, Communication Services and Consumer Discretionary. SPXV is more expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.09% for GSUS. SPXV is down -2.84% year-to-date (YTD) with - in YTD flows. GSUS performs worse with -3.25% YTD performance, and -$107M in YTD flows. Run a side-by-side ETF comparison of SPXV and GSUS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | SPXV GSUS | -2.63%-2.76% | -2.31%-2.80% | -2.84%-3.25% | +23.49%+21.70% | +87.70%+80.79% | +84.16%+76.63% |
| Flows | SPXV GSUS | --$107M | +$741K-$126M | --$107M | +$3M-$95M | +$18M+$1.00B | +$21M+$1.45B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | SPXV GSUS | +12.55%+11.89% | +19.21%+18.34% | +15.79%+14.96% | +17.89%+17.36% |
| Max drawdown | SPXV GSUS | -4.98%-5.02% | -14.32%-13.91% | -19.85%-19.14% | -26.54%-25.66% |
| Max drawdown duration | SPXV GSUS | 44d60d | 45d45d | 124d126d | 707d715d |
SPXV | GSUS | |
Last sale 3/16/2026 at 1:30 PM | $73.09 | $92.30 |
| Previous close 03/13/2026 | $72.33 | $91.33 |
| Consolidated volume 03/13/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
SPXV | GSUS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
SPXV | GSUS | |
|---|---|---|
| Last price | $73.09 | $92.30 |
| 1D performance | +1.06% | +1.06% |
| AuM | $34.72 M | $2.78 B |
| E/R | 0.13% | 0.09% |
SPXV | GSUS | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | ProShares | Goldman Sachs |
| Benchmark | S&P 500 Ex-Health Care Index | Solactive GBS United States Large & Mid Cap Index |
| N° of holdings | 423 | 400 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 22, 2015 | May 12, 2020 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
